Annual Interest Expense
$81.29 M
+$851.00 K+1.06%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual interest expense is $81.29 million, with the most recent change of +$851.00 thousand (+1.06%) on December 31, 2023.
- During the last 3 years, BBIO annual interest expense has risen by +$44.63 million (+121.77%).
- BBIO annual interest expense is now at all-time high.
Performance
BBIO Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$23.06 M
+$124.00 K+0.54%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly interest expense is $23.06 million, with the most recent change of +$124.00 thousand (+0.54%) on September 30, 2024.
- Over the past year, BBIO quarterly interest expense has increased by +$2.79 million (+13.78%).
- BBIO quarterly interest expense is now -1.75% below its all-time high of $23.47 million, reached on March 31, 2024.
Performance
BBIO Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$89.74 M
+$2.75 M+3.17%
September 30, 2024
Summary
- As of February 7, 2025, BBIO TTM interest expense is $89.74 million, with the most recent change of +$2.75 million (+3.17%) on September 30, 2024.
- Over the past year, BBIO TTM interest expense has increased by +$8.45 million (+10.39%).
- BBIO TTM interest expense is now at all-time high.
Performance
BBIO TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
BBIO Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.1% | +13.8% | +10.4% |
| 3 y3 years | +121.8% | +13.8% | +10.4% |
| 5 y5 years | +3091.6% | +13.8% | +10.4% |
BBIO Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.8% | -1.8% | +52.4% | at high | +91.8% |
| 5 y | 5-year | at high | +827.4% | -1.8% | +658.6% | at high | +923.8% |
| alltime | all time | at high | >+9999.0% | -1.8% | >+9999.0% | at high | >+9999.0% |
BridgeBio Pharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $23.06 M(+0.5%) | $89.74 M(+3.2%) |
| Jun 2024 | - | $22.94 M(-2.3%) | $86.98 M(+2.8%) |
| Mar 2024 | - | $23.47 M(+15.8%) | $84.64 M(+4.1%) |
| Dec 2023 | $81.29 M(+1.1%) | $20.27 M(-0.2%) | $81.29 M(+0.3%) |
| Sep 2023 | - | $20.31 M(-1.4%) | $81.01 M(+0.6%) |
| Jun 2023 | - | $20.59 M(+2.4%) | $80.53 M(+0.4%) |
| Mar 2023 | - | $20.12 M(+0.7%) | $80.22 M(-0.3%) |
| Dec 2022 | $80.44 M(+72.0%) | $19.99 M(+0.8%) | $80.44 M(+6.4%) |
| Sep 2022 | - | $19.82 M(-2.2%) | $75.58 M(+13.1%) |
| Jun 2022 | - | $20.28 M(-0.3%) | $66.82 M(+16.5%) |
| Mar 2022 | - | $20.34 M(+34.4%) | $57.38 M(+22.7%) |
| Dec 2021 | $46.78 M | $15.13 M(+36.7%) | $46.78 M(+9.8%) |
| Sep 2021 | - | $11.07 M(+2.1%) | $42.61 M(+0.3%) |
| Jun 2021 | - | $10.84 M(+11.3%) | $42.47 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $9.74 M(-11.2%) | $42.38 M(+15.6%) |
| Dec 2020 | $36.66 M(+318.2%) | $10.96 M(+0.3%) | $36.66 M(+27.6%) |
| Sep 2020 | - | $10.93 M(+1.6%) | $28.73 M(+44.3%) |
| Jun 2020 | - | $10.75 M(+168.2%) | $19.92 M(+79.4%) |
| Mar 2020 | - | $4.01 M(+31.9%) | $11.10 M(+26.7%) |
| Dec 2019 | $8.77 M(+244.1%) | $3.04 M(+43.9%) | $8.77 M(+27.0%) |
| Sep 2019 | - | $2.11 M(+8.9%) | $6.90 M(+16.1%) |
| Jun 2019 | - | $1.94 M(+16.2%) | $5.95 M(+41.2%) |
| Mar 2019 | - | $1.67 M(+41.7%) | $4.21 M(+65.3%) |
| Dec 2018 | $2.55 M(>+9900.0%) | $1.18 M(+2.0%) | $2.55 M(+86.2%) |
| Sep 2018 | - | $1.16 M(+463.9%) | $1.37 M(+545.3%) |
| Jun 2018 | - | $205.00 K(+2828.6%) | $212.00 K(+2928.6%) |
| Mar 2018 | - | $7000.00 | $7000.00 |
| Dec 2017 | $13.00 K | - | - |
FAQ
- What is BridgeBio Pharma annual interest expense?
- What is the all time high annual interest expense for BridgeBio Pharma?
- What is BridgeBio Pharma annual interest expense year-on-year change?
- What is BridgeBio Pharma quarterly interest expense?
- What is the all time high quarterly interest expense for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly interest expense year-on-year change?
- What is BridgeBio Pharma TTM interest expense?
- What is the all time high TTM interest expense for BridgeBio Pharma?
- What is BridgeBio Pharma TTM interest expense year-on-year change?
What is BridgeBio Pharma annual interest expense?
The current annual interest expense of BBIO is $81.29 M
What is the all time high annual interest expense for BridgeBio Pharma?
BridgeBio Pharma all-time high annual interest expense is $81.29 M
What is BridgeBio Pharma annual interest expense year-on-year change?
Over the past year, BBIO annual interest expense has changed by +$851.00 K (+1.06%)
What is BridgeBio Pharma quarterly interest expense?
The current quarterly interest expense of BBIO is $23.06 M
What is the all time high quarterly interest expense for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly interest expense is $23.47 M
What is BridgeBio Pharma quarterly interest expense year-on-year change?
Over the past year, BBIO quarterly interest expense has changed by +$2.79 M (+13.78%)
What is BridgeBio Pharma TTM interest expense?
The current TTM interest expense of BBIO is $89.74 M
What is the all time high TTM interest expense for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM interest expense is $89.74 M
What is BridgeBio Pharma TTM interest expense year-on-year change?
Over the past year, BBIO TTM interest expense has changed by +$8.45 M (+10.39%)